In addition to SCLC, DLL3 is overexpressed in other tumor cells, such as stomach cancer cells [18], isocitrate dehydrogenase-mutant glioma [19], gastrointestinal neuroendocrine cancer [20], small-cell bladder cancer [21], and some types of breast cancer [22]. This evidence concerns the gene DLL3 and glioma.